
As ACR Convergence gets underway in Chicago, Tait Shanafelt, MD, a thought leader and researcher in the field of physician well-being and its implications for quality of care, will explore organizational approaches to addressing issues in the work environment that magnify work burden and erode…
Conference Co-Chairs Laura Cappelli, MD, and Marcela Maus, MD, PhD, detail what to expect from this advance programming, including how new modalities like immunotherapies and cell therapy are being used in the clinical setting.
The eight lectures in this course represent the breadth of rheumatology, making it a one-stop shop for staying current in the field. Co-Coordinators Julie Paik, MD, MHS, and Sarah Bayefsky, MD, explain what attendees can expect.
The Exhibit Hall will be open Sunday, October 26, through Tuesday, October 28, featuring a variety of booths, educational opportunities, resources, and snacks.
In the two-part boot camp, Troy Torgerson, MD, PhD, will present a basic framework for how innate and adaptive immune responses interact to result in rheumatic disease, and how clinicians can intervene to treat patients. He also will guide participants through clinical decision-making scenarios.
Edith Williams, PhD, and other panelists will highlight strategies for improving inclusion of traditionally underrepresented groups at all levels of academic medicine, from research participants to academic teams.
Experts will share how new technology, updated guidelines, and other advancements are changing approaches to radiology used in rheumatic diseases, explains session coordinator Morgan Merchand, NP.
Janeth Yinh, MD, RhMSUS, and Fawad Aslam, MBBS, RhMSUS, MSc, FACP, FACR, detail what attendees can expect from the two levels of the pre-conference Ultrasound Conferences, including several hours of scanning practice.
Elizabeth Volkmann, MD, MS, gives an overview of what attendees can expect from the Clinical Science track in Chicago, including the diagnosis, treatment, and emerging research on diseases such as rheumatoid arthritis, lupus, and scleroderma.
Susan Shenoi, MD, MS, previews the wide-ranging program, which includes clinical challenges and updates on disease management for young patients with rheumatic disease, emerging therapies for this patient population, and new developments in basic and translational science.